Clinical & CRO support
CRO selection and clinical operations support
Clinical development decisions involve more than finding an available vendor. A sponsor needs criteria that fit the study, a clear view of operational responsibilities and a practical way to compare potential partners. Bion Med supports these decisions through partner mapping, RFP preparation, study-readiness review and coordination planning.
For pharma, biotech and other sponsor-side teams preparing a study, comparing CRO partners or clarifying how clinical work will be coordinated.
Where support can help
01CRO partner mapping and selection
Define the capabilities the study needs, map potential partners and structure a comparison around scope, responsibilities and delivery considerations. The aim is a transparent sponsor-side decision, not a preferred-vendor list.
02RFP and study readiness
Translate the study context into questions for a request for proposal and identify operational assumptions that need clarification before a partner is selected or a study moves forward.
03Clinical operations coordination
Clarify interfaces between sponsor, CRO and other vendors, including ownership of follow-up, documentation and decision points across the planned delivery process.
A practical decision process
- Clarify the study context, decision deadline and responsibilities that cannot be delegated.
- Agree on evaluation criteria and information needed from potential partners.
- Compare options and document open questions, assumptions and trade-offs.
- Translate the choice into a coordination plan with owners and next steps.
Possible working outputs
Depending on the agreed scope, the work may produce an evaluation matrix, RFP questions, a study-readiness checklist or a sponsor–CRO coordination outline. These are decision-support materials; they do not replace the sponsor's regulatory, medical or quality responsibilities.
Describe the stage of your study and the decision you need to make. We can then define whether a focused advisory engagement would be useful.